Authors
Latest:
Continuing the Fight Against Gram-Negative Infections: What's in the Pipeline—Part 3Part 3 of our series looks at
Latest:
A New Meaning to "Getting Tested"Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.
Latest:
An Unexpected Meningitis CulpritA team of physicians yields surprising findings in an elderly patient in shock with seizures.
Latest:
The Future of Health Care After COVID-19My hope is that years from now, when we look back on the coronavirus disease 2019 (COVID-19) pandemic, it will have served a few purposes.
Latest:
Neglect of Skin Wounds Is a Risk Factor for Becoming a Carrier of S. AureusA new study in BMC Public Health finds that neglect of skin wounds is an independent and strong risk factor for becoming a carrier of Staphylococcus aureus (S. aureus), a dangerous pathogen that can cause infections and lead to life-threatening infectious diseases.
Latest:
PEN-FAST Forward: Accelerating Penicillin Allergy De-LabelingPEN-FAST is a validated risk stratification tool that promotes efficient, safe, and effective de-labeling of penicillin allergies.
Latest:
COVID and Influenza Vaccinations Well Tolerated Whether Given Simultaneously or SequentiallyReactogenicity of mRNA COVID-19 with inactivated influenza vaccine was similar whether given at same time or separated by 1-2 weeks.
Latest:
Do You Have a Minute? Asking Infectious Diseases Clinicians to Provide Uncompensated ServicesID clinicians must be paid for time spent conducting unbillable work for OPAT services.
Latest:
Final Thoughts on COVID-19 and FluFinal thoughts from experts on controlling COVID-19 and influenza.
Latest:
Eosinophils, Fevers, and Diarrhea With a Surprise Diagnosis in a Patient With AIDSWhen the CD4 count seems too good to be true.
Latest:
Addressing ART Adherence in Hispanic/Latino Men Living with HIVInvestigators found these populations are younger and are living at or below poverty were at lower adherence to ART.
Latest:
A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet NeedThis training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.
Latest:
Testing Still Needed After HCV Clears in HIV-Positive MSMA retrospective study found hepatitis C reinfection rates high are in HIV-positive men who have sex with men from four western European countries.
Latest:
Lefamulin: An Overview of a Lonely SoldierLefamulin, a recently approved pleuromutilin, adds to the current antibiotic armamentarium, although its place in therapy remains to be seen.
Latest:
IDWeek 2019 News Network: Assessing Challenges to Treating CABPThomas Lodise, PharmD, PhD, provides an overview of options for treating community-acquired bacterial pneumonia and highlights the challenges of the infection.
Latest:
Final Diagnosis: Disseminated Kaposi Sarcoma With Tonsillar and Pulmonary InvolvementA shocking find on a CT scan leads to an unexpected diagnosis.
Latest:
Ebola Vaccine Offers 100% Protection Against Deadly VirusResearchers have found that an experimental vaccine designed to fight the Ebola virus has proven to be highly protective.
Latest:
Intraseasonal Influenza Vaccine Effectiveness Waning: Threading the Needle for ImmunityEvidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.
Latest:
FDA Approves Oral Sulopenem (Orlynvah) for Uncomplicated Urinary Tract InfectionsIterum Therapeutics receives approval for Orlynvah as the first oral penem for treating uncomplicated urinary tract infections in adult women with limited treatment options.
Latest:
The Multi-Drug Resistant Organism NetworkA collaborative, international effort aims to answer tough antimicrobial resistance questions.
Latest:
Preventing Multidrug-Resistant Spread in Healthcare FacilitiesThe interconnectedness of many healthcare facilities such as nursing homes, hospitals, and long-term acute-care hospitals means a significant chance of multidrug-resistant organism transmission when patients shuttle between facilities.
Latest:
Shoutout to the Stewards: Holiday EditionContagion® radio is here to bring joy with every new antibiotic alert!
Latest:
How Obamacare Will Affect HIV/AIDS PreventionNoting successful HIV/AIDS prevention efforts rely on early diagnosis, an analysis estimates that improved access to health insurance through the Affordable Care Act will increase the number of patients getting tested for HIV by nearly 500,000 over a 5-year period, though that impact would be amplified if all US states opted to expand Medicaid coverage.
Latest:
President Trump and First Lady Test Positive for COVID-19President Donald Trump broke the news last night via Twitter.
Latest:
Taking A Closer Look at Shingrix: The New Shingles VaccineThe only way individuals can reduce their risk of getting shingles is to get vaccinated; luckily, a new vaccine has recently been approved by the FDA.
Latest:
An Unknown Contagious Rash: Case Report and Literature Review of Norwegian Crusted ScabiesA patient with HIV and skin lesions should trigger a broad differential.
Latest:
Fecal Transplant Benefits C diff Patients Coinfected With COVID-19Treating Clostridioides difficile infection is complicated in patients coinfected with COVID-19. However, a new study suggests a significant benefit of fecal microbiota transplant (FMT) in these coinfected patients.
Latest:
Four Fungal Horsemen: Emerging Trends in Fungal Disease EpidemiologyNew public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
Latest:
Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube DefectsThere has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
